61I Stock Overview
Through its subsidiaries, provides cloud-based software-as-a-service research platform.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 4/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Research Solutions, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$2.40 |
52 Week High | US$3.12 |
52 Week Low | US$1.79 |
Beta | 0.64 |
11 Month Change | 0% |
3 Month Change | -17.81% |
1 Year Change | 29.03% |
33 Year Change | 4.35% |
5 Year Change | n/a |
Change since IPO | 19.67% |
Recent News & Updates
Recent updates
Shareholder Returns
61I | DE IT | DE Market | |
---|---|---|---|
7D | -0.8% | -2.1% | 0.8% |
1Y | 29.0% | 2.1% | 2.0% |
Return vs Industry: 61I exceeded the German IT industry which returned 2.1% over the past year.
Return vs Market: 61I exceeded the German Market which returned 2% over the past year.
Price Volatility
61I volatility | |
---|---|
61I Average Weekly Movement | 5.5% |
IT Industry Average Movement | 4.7% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.3% |
10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: 61I's share price has been volatile over the past 3 months.
Volatility Over Time: 61I's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2006 | 145 | Roy Olivier | www.researchsolutions.com |
Research Solutions, Inc., through its subsidiaries, provides cloud-based software-as-a-service research platform. The company is also involved in the transactional sale of published scientific, technical, and medical (STM) content managed, sourced, and delivered through the Transactions platform. Its solutions enable life science and other research intensive organizations to accelerate their research and development activities with access and management STM articles used throughout the intellectual property development lifecycle.
Research Solutions, Inc. Fundamentals Summary
61I fundamental statistics | |
---|---|
Market cap | €72.16m |
Earnings (TTM) | -€550.41k |
Revenue (TTM) | €39.63m |
1.8x
P/S Ratio-131.1x
P/E RatioIs 61I overvalued?
See Fair Value and valuation analysisEarnings & Revenue
61I income statement (TTM) | |
---|---|
Revenue | US$42.45m |
Cost of Revenue | US$24.53m |
Gross Profit | US$17.92m |
Other Expenses | US$18.51m |
Earnings | -US$589.62k |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.019 |
Gross Margin | 42.21% |
Net Profit Margin | -1.39% |
Debt/Equity Ratio | 0% |
How did 61I perform over the long term?
See historical performance and comparison